• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G140
Device Problems Failure to Convert Rhythm (1540); Inaccurate Synchronization (1609)
Patient Problems Ventricular Fibrillation (2130); Electric Shock (2554)
Event Date 05/01/2022
Event Type  Injury  
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d), presented for a routine follow-up and had mentioned that the patient was hospitalized in may with ventricular fibrillation (vf).The episode showed anti-tachycardia pacing (atp) with five 41 joule shocks.The atp accelerated the vf and the device delivered four shocks without success, the fifth shock converted the vf rhythm, and the shock impedance was in range.The physician suspects that the ineffective shocks were not due to the device but possibly due to patient condition lamina.The atp pre-shock was disabled, and the plan is to perform an x-ray to evaluate the position of the lead coil at the next follow-up in the next six to eight months.No additional adverse patient effects were reported.This device and right ventricular lead remain in-service.
 
Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.Please refer to b5 describe event or problem for more information regarding the specific circumstances of this event.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d), presented for a routine follow-up and had mentioned that the patient was hospitalized in may with ventricular fibrillation (vf).The episode showed anti-tachycardia pacing (atp) with five 41 joule shocks.The atp accelerated the vf and the device delivered four shocks without success, the fifth shock converted the vf rhythm, and the shock impedance was in range.The physician suspects that the ineffective shocks were not due to the device but possibly due to patient condition lamina.The atp pre-shock was disabled, and the plan is to perform an x-ray to evaluate the position of the lead coil at the next follow-up in the next six to eight months.No additional adverse patient effects were reported.This device and right ventricular lead remain in-service.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16127419
MDR Text Key306972863
Report Number2124215-2022-56309
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534539
UDI-Public00802526534539
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date10/19/2019
Device Model NumberG140
Device Catalogue NumberG140
Device Lot Number488517
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/15/2022
Initial Date FDA Received01/09/2023
Supplement Dates Manufacturer Received01/16/2023
Supplement Dates FDA Received01/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/31/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization;
-
-